Skip to main content
Clinical Trials/NL-OMON54925
NL-OMON54925
Recruiting
Not Applicable

Management of the combination of tacrolimus with azoles: effect of tacrolimus formulation on drug-drug interaction magnitude - TAFI study

niversitair Medisch Centrum Groningen0 sites24 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mycoses due to opportunistic pathogens
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
24
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Lung, kidney, pancreas or heart transplant recipient
  • \- Age \>18 years
  • \- Stable use of tacrolimus formulations Prograf/generic tacrolimus/Envarsus
  • \- Indication for antifungal therapy with voriconazole
  • \- Written informed consent

Exclusion Criteria

  • \- Administration of mTOR inhibitors, cyclosporine or quadruple immunosuppression
  • \- Concomitant use of drugs that have a pharmacokinetic interaction with
  • \- Acute liver\- or intestinal function impairment
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials